Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Vaccinex, Inc.

NASDAQ: VCNXHealthcare / Biotechnology / USA
5.50-0.0500-0.90%Vol 19 1321Y Perf -50.97%
Apr 17th, 2019 16:00
BID5.50 ASK5.70
Open5.30 Previous Close5.55
Pre-Market- After-Trading-
 - -%  - -%
Target Price
22.00 
Analyst Rating
— — 0.00
Potencial %
300.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)63 
Earnings Rating
Price Range Ratio 52wk %
25.12 
Earnings Date
12th Jun 2019

Today's Price Range

5.146.10

 

52wk Range

3.3212.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
35.80%
3 Months
11.56%
6 Months
-21.43%
1 Year
-50.97%
3 Years
-
5 Years
-

Name / TickerPriceChg.Chg.%
VCNX5.50-0.0500-0.90
AAPL203.133.88001.95
GOOG1 236.349.21000.75
MSFT121.771.00000.83
XOM81.430.23000.28
WFC47.55-0.1000-0.21
JNJ138.520.50000.36
FB178.78-0.0900-0.05
GE9.12-0.0200-0.22
JPM114.303.20002.88
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
3.00
Current Ratio
3.20
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-74.30
Leverage Ratio -0.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-76.80
EBIT Margin
-4 569.60
EBITDA Margin
-4 536.10
Pre-tax Profit Margin
-
Profit Margin
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.58-0.93-60.34
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date12th Jun 2019
Estimated EPS Next Report-0.68
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume19 132
Shares Outstanding (in ths.)11 476
Trades Count98
Dollar Volume96 776
Avg. Volume11 415
Avg. Weekly Volume23 458
Avg. Monthly Volume22 624
Avg. Quarterly Volume12 410

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

75%25%

Bearish Bullish

60%40%

Bearish Bullish

43%57%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News